The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, B.
Right arrow Articles by Frelinger, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, B.
Right arrow Articles by Frelinger, J. A.
The Journal of Immunology, 2000, 164: 1216-1222.
Copyright © 2000 by The American Association of Immunologists

Naive CD8+ T Cells Do Not Require Costimulation for Proliferation and Differentiation into Cytotoxic Effector Cells1

Bo Wang*, Robert Maile*, Roberta Greenwood*, Edward J. Collins*,{dagger} and Jeffrey A. Frelinger2,*

Departments of * Microbiology and Immunology and {dagger} Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC 27599

Most current models of T cell activation postulate a requirement for two distinct signals. One signal is delivered through the TCR by engagement with peptide/MHC complexes, and the second is delivered by interaction between costimulatory molecules such as CD28 and its ligands CD80 and CD86. Soluble peptide/MHC tetramers provide an opportunity to test whether naive CD8+ T cells can be activated via the signal generated through the TCR-{alpha}ß in the absence of any potential costimulatory molecules. Using T cells from two different TCR transgenic mice in vitro, we find that TCR engagement by peptide/MHC tetramers is sufficient for the activation of naive CD8+ T cells. Furthermore, these T cells proliferate, produce cytokines, and differentiate into cytolytic effectors. Under the conditions where anti-CD28 is able to enhance proliferation of normal B6 CD4+, CD8+, and TCR transgenic CD8+ T cells with anti-CD3, we see no effect of anti-CD28 on proliferation induced by tetramers. The results of this experiment argue that given a strong signal delivered through the TCR by an authentic ligand, no costimulation is required.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Tian, R. Maile, E. J. Collins, and J. A. Frelinger
CD8+ T Cell Activation Is Governed by TCR-Peptide/MHC Affinity, Not Dissociation Rate
J. Immunol., September 1, 2007; 179(5): 2952 - 2960.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. R. Hess, C. Barnes, M. D. Woolard, M. D. L. Johnson, J. M. Cullen, E. J. Collins, and J. A. Frelinger
Selective deletion of antigen-specific CD8+ T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin
Blood, April 15, 2007; 109(8): 3300 - 3307.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. D. Woolard, J. E. Wilson, L. L. Hensley, L. A. Jania, T. H. Kawula, J. R. Drake, and J. A. Frelinger
Francisella tularensis-Infected Macrophages Release Prostaglandin E2 that Blocks T Cell Proliferation and Promotes a Th2-Like Response
J. Immunol., February 15, 2007; 178(4): 2065 - 2074.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Martin-Orozco, Y.-H. Wang, H. Yagita, and C. Dong
Cutting Edge: Programed Death (PD) Ligand-1/PD-1 Interaction Is Required for CD8+ T Cell Tolerance to Tissue Antigens
J. Immunol., December 15, 2006; 177(12): 8291 - 8295.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Cesson, K. Stirnemann, B. Robert, I. Luescher, T. Filleron, G. Corradin, J.-P. Mach, and A. Donda
Active Antiviral T-Lymphocyte Response Can Be Redirected against Tumor Cells by Antitumor Antibody x MHC/Viral Peptide Conjugates
Clin. Cancer Res., December 15, 2006; 12(24): 7422 - 7430.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Maile, C. M. Barnes, A. I. Nielsen, A. A. Meyer, J. A. Frelinger, and B. A. Cairns
Lymphopenia-Induced Homeostatic Proliferation of CD8+ T Cells Is a Mechanism for Effective Allogeneic Skin Graft Rejection following Burn Injury.
J. Immunol., June 1, 2006; 176(11): 6717 - 6726.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
I. Klein and I. N. Crispe
Complete differentiation of CD8+ T cells activated locally within the transplanted liver
J. Exp. Med., February 21, 2006; 203(2): 437 - 447.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Maile, C. A. Siler, S. E. Kerry, K. E. Midkiff, E. J. Collins, and J. A. Frelinger
Peripheral "CD8 Tuning" Dynamically Modulates the Size and Responsiveness of an Antigen-Specific T Cell Pool In Vivo
J. Immunol., January 15, 2005; 174(2): 619 - 627.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Lev, R. Noy, K. Oved, H. Novak, D. Segal, P. Walden, D. Zehn, and Y. Reiter
Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo
PNAS, June 15, 2004; 101(24): 9051 - 9056.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. E. Kerry, J. Buslepp, L. A. Cramer, R. Maile, L. L. Hensley, A. I. Nielsen, P. Kavathas, B. J. Vilen, E. J. Collins, and J. A. Frelinger
Interplay between TCR Affinity and Necessity of Coreceptor Ligation: High-Affinity Peptide-MHC/TCR Interaction Overcomes Lack of CD8 Engagement
J. Immunol., November 1, 2003; 171(9): 4493 - 4503.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. S. Vacchio and R. J. Hodes
CD28 Costimulation Is Required for In Vivo Induction of Peripheral Tolerance in CD8 T Cells
J. Exp. Med., January 6, 2003; 197(1): 19 - 26.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Buslepp, S. E. Kerry, D. Loftus, J. A. Frelinger, E. Appella, and E. J. Collins
High Affinity Xenoreactive TCR:MHC Interaction Recruits CD8 in Absence of Binding to MHC
J. Immunol., January 1, 2003; 170(1): 373 - 383.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Kovacs, M. V. Maus, J. L. Riley, G. S. Derimanov, G. A. Koretzky, C. H. June, and T. H. Finkel
Human CD8+ T cells do not require the polarization of lipid rafts for activation and proliferation
PNAS, November 12, 2002; 99(23): 15006 - 15011.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Schott, N. Bertho, Q. Ge, M. M. Maurice, and H. L. Ploegh
Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules
PNAS, October 15, 2002; 99(21): 13735 - 13740.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Lev, H. Novak, D. Segal, and Y. Reiter
Recruitment of CTL Activity by Tumor-Specific Antibody-Mediated Targeting of Single-Chain Class I MHC-Peptide Complexes
J. Immunol., September 15, 2002; 169(6): 2988 - 2996.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Wang, A. Sharma, R. Maile, M. Saad, E. J. Collins, and J. A. Frelinger
Peptidic Termini Play a Significant Role in TCR Recognition
J. Immunol., September 15, 2002; 169(6): 3137 - 3145.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Demirci, W. Gao, X. X. Zheng, T. R. Malek, T. B. Strom, and X. C. Li
On CD28/CD40 Ligand Costimulation, Common {gamma}-Chain Signals, and the Alloimmune Response
J. Immunol., May 1, 2002; 168(9): 4382 - 4390.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Y. Kim and H.-S. Teh
TNF Type 2 Receptor (p75) Lowers the Threshold of T Cell Activation
J. Immunol., December 15, 2001; 167(12): 6812 - 6820.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Hombach, A. Wieczarkowiecz, T. Marquardt, C. Heuser, L. Usai, C. Pohl, B. Seliger, and H. Abken
Tumor-Specific T Cell Activation by Recombinant Immunoreceptors: CD3{zeta} Signaling and CD28 Costimulation Are Simultaneously Required for Efficient IL-2 Secretion and Can Be Integrated Into One Combined CD28/CD3{zeta} Signaling Receptor Molecule
J. Immunol., December 1, 2001; 167(11): 6123 - 6131.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H.-W. Mittrucker, M. Kursar, A. Kohler, R. Hurwitz, and S. H. E. Kaufmann
Role of CD28 for the Generation and Expansion of Antigen-Specific CD8+ T Lymphocytes During Infection with Listeria monocytogenes
J. Immunol., November 15, 2001; 167(10): 5620 - 5627.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. M. Padigel, P. J. Perrin, and J. P. Farrell
The Development of a Th1-Type Response and Resistance to Leishmania major Infection in the Absence of CD40-CD40L Costimulation
J. Immunol., November 15, 2001; 167(10): 5874 - 5879.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Y. Tsang, M. Zhu, J. Even, J. Gulley, P. Arlen, and J. Schlom
The Infection of Human Dendritic Cells with Recombinant Avipox Vectors Expressing a Costimulatory Molecule Transgene (CD80) to Enhance the Activation of Antigen-specific Cytolytic T Cells
Cancer Res., October 1, 2001; 61(20): 7568 - 7576.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Maile, B. Wang, W. Schooler, A. Meyer, E. J. Collins, and J. A. Frelinger
Antigen-Specific Modulation of an Immune Response by In Vivo Administration of Soluble MHC Class I Tetramers
J. Immunol., October 1, 2001; 167(7): 3708 - 3714.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Piccirillo and E. M. Shevach
Cutting Edge: Control of CD8+ T Cell Activation by CD4+CD25+ Immunoregulatory Cells
J. Immunol., August 1, 2001; 167(3): 1137 - 1140.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Wang, C. C. Norbury, R. Greenwood, J. R. Bennink, J. W. Yewdell, and J. A. Frelinger
Multiple Paths for Activation of Naive CD8+ T Cells: CD4-Independent Help
J. Immunol., August 1, 2001; 167(3): 1283 - 1289.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Hombach, D. Sent, C. Schneider, C. Heuser, D. Koch, C. Pohl, B. Seliger, and H. Abken
T-Cell Activation by Recombinant Receptors: CD28 Costimulation Is Required for Interleukin 2 Secretion and Receptor-mediated T-Cell Proliferation but Does Not Affect Receptor-mediated Target Cell Lysis
Cancer Res., March 1, 2001; 61(5): 1976 - 1982.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
H. Ito, J. Kurtz, J. Shaffer, and M. Sykes
CD4 T Cell-Mediated Alloresistance to Fully MHC-Mismatched Allogeneic Bone Marrow Engraftment Is Dependent on CD40-CD40 Ligand Interactions, and Lasting T Cell Tolerance Is Induced by Bone Marrow Transplantation with Initial Blockade of this Pathway
J. Immunol., March 1, 2001; 166(5): 2970 - 2981.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Grayson, K. Murali-Krishna, J. D. Altman, and R. Ahmed
Gene Expression in Antigen-Specific CD8+ T Cells During Viral Infection
J. Immunol., January 15, 2001; 166(2): 795 - 799.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Williams, J. Trambley, J. Ha, A. B. Adams, M. M. Durham, P. Rees, S. R. Cowan, T. C. Pearson, and C. P. Larsen
Genetic Characterization of Strain Differences in the Ability to Mediate CD40/CD28-Independent Rejection of Skin Allografts
J. Immunol., December 15, 2000; 165(12): 6849 - 6857.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D.-G. Lim, K. Bieganowska Bourcier, G. J. Freeman, and D. A. Hafler
Examination of CD8+ T Cell Function in Humans Using MHC Class I Tetramers: Similar Cytotoxicity but Variable Proliferation and Cytokine Production Among Different Clonal CD8+ T Cells Specific to a Single Viral Epitope
J. Immunol., December 1, 2000; 165(11): 6214 - 6220.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zhan, A. J. Corbett, J. L. Brady, R. M. Sutherland, and A. M. Lew
CD4 Help-Independent Induction of Cytotoxic CD8 Cells to Allogeneic P815 Tumor Cells Is Absolutely Dependent on Costimulation
J. Immunol., October 1, 2000; 165(7): 3612 - 3619.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.